Great post, boss!
I wanted to point out one further detail in the agreement:
"The OEM agreement provides Scott with the right to sell ClearCalm under its own brand. Scott will have exclusive use of ClearCalm technology for respiratory protection devices including, open-circuit SCBA and negative pressure respiratory protection devices, powered air purifying respirators, and self-contained air-line breathing apparatus (SABA) with exclusive territory rights in North America, including U.S. territories, and non-continental U.S., United Kingdom, Australia and New Zealand. Scott will also have non-exclusive technology rights in the closed-circuit SCBA and re-breather markets and right of first refusal for future technology enhancements and development in the defined markets and territories. The deal is for two years with a renewal option."
Now, I'm sure that Scott wants to maximize their market-share, and it seems to me that they are extremely confident in the ClearCalm system to help them do that. I'm also sure that Grayling wants to sell as many units as possible, so, for them to agree to a two year, renewable, exclusive agreement with Scott, the terms had to be very favorable - what I'm getting at here, is they would not enter into such an agreement on a loss-leader basis - selling units at or near their cost, just to gain market exposure. This is going to be a very profitable venture for Scott, Grayling, and us investors!!
In summary - Weeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee!
Market Data 
Markets 
AI
